VerbatimParliament, as it happens

Respiratory Diseases: Drugs and Innovation

Asked by Rachel GilmourLiberal DemocratDepartment of Health and Social CareTabled Answered 3 March 2026UIN 115251

The question

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Department for Science and Technology about the potential for a respiratory Modern Service Framework to strengthen the UK’s life sciences ecosystem by scaling up the adoption of new medicines and innovations for lung conditions.

Answered by Dr Zubir Ahmed

The Government will consider long-term conditions for future waves of modern service frameworks (MSFs), including respiratory conditions. The criteria for determining other conditions for future MSFs will be based on where there is potential for rapid and significant improvements in quality of care and productivity. After the initial wave of MSFs is complete, the National Quality Board will determine the conditions to prioritise for new MSFs as part of its work programme.

NHS England and the Department of Health and Social Care are working with the Department for Science, Innovation and Technology to explore innovation and policy prioritisation in respiratory health, including the cross‑Government alignment that may be required.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim